Delivery Order SPE2DB24D3013-SPE2DB25FFQPZ
Award Date 9/15/25
Potential Completion Date 10/6/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TABRECTA 200 mg tablets in quantities of 56 units. This is a firm fixed-price contract with a ceiling value of $14.4K and an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and represents a competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $21,325.14 on September 5, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 26, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, PA, was awarded a delivery order valued at $10,662.57 by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price, non-competitive delivery order is scheduled for completion by May 12, 2025, and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. The award was...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $21,325.14 and an ultimate completion date of September 30, 2025. This non-set-aside competitive award represents a child delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for Truqap 200 mg tablets (64-count units) with a ceiling value of $15,514.40. The contract, which is not set-aside and competitively awarded, carries a firm fixed price structure and an ultimate completion date of June 24, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price arrangement with a ceiling value of $42,650.28 and an ultimate completion date of June 27, 2025. This non-set-aside, competitively awarded delivery order represents a continuation of the federal government's reliance on AmerisourceBergen as a critical pharmaceutical distributor for...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,924.54 on July 24, 2025, for the supply of Mektovi 15 mg tablets (180-count units). This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, was issued through the Defense Logistics Agency's Medical Supply Chain as a non-set-aside competitive award. The contract represents a child delivery order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $18,339.50 on July 18, 2025, with an ultimate completion date of July 21, 2025. The award is for Gemtesa 75 mg tablets in a quantity of 90 units under a firm fixed price contract type with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, by the Defense Logistics Agency for the supply of ATTRUBY 356 mg tablets (28 count). The contract, valued at $12,778.22, carries a firm fixed price structure with an ultimate completion date of August 20, 2025. This is a non-set-aside competitive award, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement...